immunogenomics, immunotherapy, immunology, cell based therapy
The Oncogenomics section of the Genetics Branch is a multidisciplinary and interdisciplinary translational research programmatic effort with the goal of utilizing genomics to develop novel immunotherapies for cancer. Our group is applying high throughput applied genomics methods including single cell RNAseq, single cell TCR sequencing, DNA sequencing, CRISPR/Cas9, bioinformatics combined with T cell based therapeutics to identify and develop novel immunotherapeutics for human cancer. We work with other investigators within the intramural program as well as industrial and pharmaceutical partners to rapidly translate our findings to the clinic. The program takes advantage of the uniqueness of the National Cancer Institute, (NCI), Center for Cancer Research (CCR) intramural program in that it spans high-risk basic discovery research in immunology, genomics and tumor biology, through preclinical translational research, to paradigm-shifting clinical trials. The position is available immediately.
The appointment duration is up to 5 years. Stipends are commensurate with education and experience.
Additional information can be found on Dr. Khan’s profile page: https://ccr.cancer.gov/Genetics-Branch/javed-khan
We are looking for postdoctoral fellows with experience or knowledge in immunogenomics, immunotherapy, immunology, cell based therapy. Experience in cell based therapeutics is preferred but not required. The postdoctoral fellows will develop novel T cell receptor (TCR) and chimeric antigen receptor (CAR) T cell therapies against cancers using sophisticated immunogenomic approaches. Candidates are required to have a Ph.D. or M.D. degree, or equivalent, in immunology, molecular/cell biology or experimental pathology.
Applicants should submit a cover letter describing their research experience and interests, CV including bibliography, and contact information for three references to: Dr. Javed Khan, M.D., via e-mail: firstname.lastname@example.org. No calls, please. If we are interested, you will be contacted by Dr. Khan.
HHS, NIH, and NCI are Equal Opportunity Employers